Navigation Links
NIH extends commitment to transformative research with 2008 Pioneer, New Innovator Awards
Date:9/21/2008

Grant Assistant Professor of Chemistry, who will build an immune system-on-a-chip to illuminate the mechanisms of, and possible therapeutic approaches to, allergic conditions.

  • Shelli Kesler, Ph.D., Stanford University School of Medicine assistant professor of psychiatry and behavioral sciences, who will develop and test intervention programs for preventing and treating cognitive impairments related to chemotherapy in women with breast cancer.

  • Yuriy Kirichok, Ph.D., University of California, San Francisco, assistant professor of physiology, who will study molecular mechanisms of cell energy production and cell death to open new avenues in the treatment of age-related metabolic and degenerative diseases.

  • Sanjay Kumar, M.D., Ph.D., University of California, Berkeley, assistant professor of bioengineering, who will combine approaches from biophysics, systems biology, and oncology to study how cells sense and process mechanical forces in human health and disease.

  • Chay T. Kuo, M.D., Ph.D., Duke University Medical Center assistant professor of cell biology and pediatrics, who will develop new genetic and chemical screening approaches in mice to identify signals regulating repair and remodeling after brain injuries.

  • Lara K. Mahal, Ph.D., University of Texas at Austin assistant professor of chemistry and biochemistry, who will develop a systems-based approach to decode how sugar molecules on cell surfaces encode information such as cell type and health.

  • Coleen T. Murphy, Ph.D., Princeton University/Lewis-Sigler Institute assistant professor of molecular biology and genomics, who will study the causes of reproductive aging and help identify candidates for the treatment and prevention of age-related reproductive decline and maternal age-related birth defects.

  • Ken-ichi Noma, Ph.D., Wistar Institute assistant professor in gene expression and regulation, who will develop a new methodolog
    '/>"/>

  • Contact: Ann Dieffenbach
    dieffena@nigms.nih.gov
    301-496-7301
    NIH/National Institute of General Medical Sciences
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7 8 9

    Related biology news :

    1. DOE JGI extends the capabilities of the Integrated Microbial Genome System
    2. Successful cooperation extends Dragon Program
    3. Thinking makes it so: Science extends reach of prosthetic arms
    4. FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change
    5. U of M researchers identify gene linked to common ailment in labrador retrievers
    6. Friendly bacteria protect against type 1 diabetes, Yale researchers find
    7. Life Sciences Discovery Fund advances latest research proposals
    8. Using novel tool, UD researchers dig through cell trash and find treasure
    9. Longevity, cancer and diet connected: New research in worms could apply to humans
    10. Research pushes back history of crop development 10,000 years
    11. Nanotechnology: A brave new world requires bold new research approaches
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
    (Date:8/20/2015)... Calif. , Aug. 20, 2015   ... focused on improving the user experience and security ... vision technologies, today announced that its TrulySecure™ ... biometric authentication software to be FIDO Certified™. ... TrulySecure for compliance with the FIDO UAF (Universal ...
    (Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
    Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 2TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 3TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 4TrulySecure From Sensory Becomes First Face and Voice Biometrics Technology to be FIDO UAF Certified 5Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2
    ... of two tiny marine algae, a team of scientists ... research in algal physiology, plant biology, and marine ecology. ... Monterey Bay Aquarium Research Institute (MBARI) and the Joint ... effort between MBARI, JGI, and an international consortium of ...
    ... CREEK, Calif. Scientists from two-dozen research organizations led by ... (JGI) and the Monterey Bay Aquarium Research Institute (MBARI) ... genes enabling them to capture carbon and maintain its ... a team led by Alexandra Z. Worden of MBARI ...
    ... North Carolina at Chapel Hill School of Medicine have identified ... the most deadly types of cancer, and discovered how a ... and potential treatment apply to a type of brain tumor ... larger group of brain tumors called malignant gliomas, which is ...
    Cached Biology News:Genes from tiny marine algae suggest unsuspected avenues for new research 2Genes from tiny marine algae suggest unsuspected avenues for new research 3Genes from tiny marine algae suggest unsuspected avenues for new research 4Genes from tiny algae shed light on big role managing carbon in world's oceans 2Genes from tiny algae shed light on big role managing carbon in world's oceans 3UNC study: Scientists identify chemical compound that may stop deadly brain tumors 2
    (Date:8/31/2015)... , Aug. 31, 2015  RXi Pharmaceuticals ... focused on discovering and developing innovative therapies primarily ... announced that the 30-day review period following the ... for ocular indications with the U.S. Food and ... is now active. Logo -  ...
    (Date:8/31/2015)... 31, 2015 Trimb Healthcare AB ("Trimb") today ... YouMedical Group BV ("YouMedical"), a Dutch OTC company with ... sales of approximately EUR 16 million, with solid growth ... "Our ambition is to build a leading international OTC ... that goal. YouMedical gives us a stronger North European ...
    (Date:8/30/2015)... , August 31, 2015 , ... Frau   für chirurgische   Behandlung     ... 7-90   werden für eine   verheerende   Geburtsverletzung ... behandeln und die Anzahl ausgebildeter Chirurgen in Kenia bis ... gab heute bekannt, dass  Action on Fistula  seit ihrem ...
    (Date:8/28/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) ... on the development of autologous cell therapies, today ... 30, 2015, corporate highlights, and near-term milestones.  The ... at www.sedar.com ,  www.edgar.com and ... expects to launch its RCS-01 treatment for aging ...
    Breaking Biology Technology:RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 2RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 3RXi Pharmaceuticals Announces Advancements in its Ophthalmology Clinical Program with RXI-109 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 2Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 3Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 4Über 550 Frauen, deren Leben durch "Action on Fistula" transformiert wurde 5RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5
    ... Mich., April 16 Lycera Corp. today announced it ... which is developing novel small-molecule pharmaceuticals to treat autoimmune ... has received $10 million as a first tranche of ... proceeds in two tranches as specific milestones are met. ...
    ... Bioscience Inc have successfully implemented Amphora,s PatentSafe solution ... using PatentSafe as a fully electronic lab notebook, ... more efficiently into today,s laboratories but it also ... simply and effectively, saving significant time previously spent ...
    ... One,Medical, Inc. ("China Sky One Medical" or "the Company") ... company producing over-the-counter,drugs in the People,s Republic of China ... and fiscal year ended December 31,2008. , , ... -- Total revenues increased 104.0% year-over-year to $26.0 million, ...
    Cached Biology Technology:Lycera Closes $36 Million Series A Financing 2Lycera Closes $36 Million Series A Financing 3Lycera Closes $36 Million Series A Financing 4Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 2Solidus Bioscience Protect their Research and Improve Efficiency With Amphora's PatentSafe Solution 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 2China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 3China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 4China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 5China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 6China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 7China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 8China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 9China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2008 Results 10
    ...
    ... the first biological reagent that ... and not just by inhibiting ... anti-mycoplasma agent that can be ... directly. The cytotoxicity of Mynox ...
    ... can be used to label ... covalently bound acridinium NHS ester ... presence of hydrogen peroxide. Acridinium ... used as a detection method ...
    ... mobility shift assay (EMSA) is a powerful ... to as gel shift or gel retardation, ... that when subjected to electrophoresis, free DNA ... The Pierce LightShift Chemiluminescent EMSA Kit is ...
    Biology Products: